UC San Diego Researchers Receive New CIRM Funding
May 25, 2012
…mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer’s disease.
May 25, 2012
…mutations that cause amyotrophic lateral sclerosis and finding new drugs to treat heart failure and Alzheimer’s disease.
December 6, 2016
small molecules that bind to them, known as ligands, interact. The method, called Transient Induced Molecular Electronic Spectroscopy (TIMES), could be used as a tool to better understand protein chemistry and to accelerate drug discovery and development.
September 6, 2017
…Master of Science in Drug Development and Product Management. This is the pharmacy school’s first master’s degree program. The program is intended for experienced professionals to gain managerial and regulatory knowledge required to lead all aspects of the drug development process, from discovery to clinical application in managed markets.
January 2, 2014
…limiting the development of human stem cell therapies. Their discovery may also provide scientists with a better understanding of how tumors evade the human immune system when they spread throughout the body.
March 19, 2015
…of collaboration that sparks discoveries, advances society and drives economic impact. Khosla added, “A primary driver of our competitiveness is the ability of our researchers to think and work across disciplines. We develop innovative approaches to solve complex problems.” For example: UC San Diego is leading Cal-BRAIN, a state-wide complement…
August 13, 2019
UC San Diego researchers discovered that removing a single enzyme in mice dramatically boosts survival from sepsis, an often fatal over-reaction of the immune system to infection. The finding provides a new and unexpected therapeutic target for new drug development.
July 21, 2023
Researchers have created a resource for analyzing how viruses infect human cells. The fruit fly-based toolkit provides a shortcut for assessing SARS-CoV-2 genes and understanding how they interact with human proteins, offering researchers a resource for new COVID-related drug therapies.
October 8, 2015
…Ph.D. A Pediatric Cancer Drug Three Decades in the Making By the age of 4, Matthew Haemsch had undergone 16 rounds of chemotherapy and a surgery to remove a cancerous tumor on his adrenal gland. Yet, his small body remained riddled with a rare pediatric cancer. With no other treatment…
August 4, 2022
Illumina Supports Enhanced Genomics-Enabled Discovery and Training Programs at UC San Diego New laboratory automation technology will advance marine biomedical research, preparing students for biotech workforce The Illumina Laboratory in Scholander Hall is one of two new automation Hubbs on the Scripps Oceanography campus. Photos by Erik Jepsen/University Communications. Scripps…
October 30, 2015
…search for molecules that could be developed into glioblastoma drugs. In mouse models of human glioblastoma, one molecule they found shrank the average tumor size by half. The study is published October 30 by Oncotarget.